ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

March 4, 1983

ACCC Joins ONS In Opposing RCT Caregiver Category

March 31, 1989

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010